Related Experiment Video
Updated: Aug 14, 2025

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
Postoperative coagulopathy among otherwise healthy pediatric patients undergoing open craniosynostosis repair: a
Shiri Zarour1, Shlomi Constantini2, Jonathan Roth2
1Division of Anesthesia, Intensive Care, and Pain Management, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel.
Insights
Routine transfusion of non-red blood cell products is not necessary for healthy pediatric patients experiencing significant blood loss during craniosynostosis surgery. Packed red blood cell transfusions alone are sufficient for safe management, preventing coagulopathy.
Area of Science:
- Pediatric Surgery
- Hematology
- Anesthesiology
Background:
- Significant intra-operative blood loss and subsequent transfusions can lead to coagulopathy.
- The necessity of routine non-red blood cell (non-RBC) blood product transfusions in pediatric patients with substantial blood loss is debated.
- Potential adverse effects exist from both coagulopathy and blood product administration.
Purpose of the Study:
- To evaluate the need for routine non-RBC blood product transfusions in healthy pediatric patients undergoing open craniosynostosis surgery with significant intra-operative blood loss.
- To assess the safety and efficacy of managing significant blood loss solely with packed red blood cells (pRBCs) and intravenous fluids.
Main Methods:
- Retrospective cohort study of 457 otherwise healthy pediatric patients undergoing open craniosynostosis surgery between 2010 and 2021.
- Patients were transfused exclusively with pRBCs.
- Analysis of postoperative coagulopathy incidence, transfusion rates, and hospital/ICU length of stay (LOS).
Main Results:
- A low incidence of significant postoperative coagulopathy was observed (7.4%).
- No statistically significant difference in coagulopathy was found between patients receiving different volumes of pRBCs.
- Hospital LOS and ICU LOS were not clinically significantly impacted by pRBC transfusion volumes.
Conclusions:
- Open craniosynostosis surgery serves as a valid model for studying coagulopathy in pediatric patients with significant blood loss.
- In healthy pediatric patients, significant intra-operative blood loss can be safely managed with intravenous fluids and pRBC transfusion alone.
- Routine non-RBC blood product transfusion is not indicated in this patient population, minimizing risks associated with unnecessary transfusions.
Abstract:
Significant blood loss and resultant transfusion may lead to coagulopathy. The need for routine transfusion of non-RBC blood products in healthy pediatric patients suffering significant, yet controlled, intra-operative blood loss is controversial. Open craniosynostosis surgery is often associated with significant intra-operative blood loss and transfusion, and routinely preformed on otherwise healthy pediatric patients. Therefore, we found it as a useful model for our study, which aimed to assess the need for routine transfusion of non-RBC blood products in healthy pediatric patients suffering significant intra-operative blood loss. We conducted a retrospective cohort study of otherwise healthy pediatric patients, undergoing open craniosynostosis surgery and transfused solely with packed red blood cells (pRBCs) in a single large-volume tertiary surgical center, between January 2010 and December 2021. Among 457 eligible patients, 34 (7.4%) developed significant postoperative coagulopathy. Median [IQR] intra-operative pRBC transfusion volume was 17.4 ml kg-1 [13.3, 23.1]. Patients who developed coagulopathy did not have higher postoperative pRBC transfusion rate (8.8% vs 3.8%, P = 0.16) or volume (median [IQR], 0 [0, 0] vs 0 [0, 0] ml, P = 0.15), nor higher hospital LOS (5 [4, 5] vs 5 [4, 5] days, P = 0.66). ICU LOS was 0.8 [0.7, 1] vs 0.7 [0.6, 0.8] days (P = 0.02), a difference of no clinical significance. Conclusions: The incidence of significant coagulopathy after craniosynostosis surgery was low, and not associated with clinically important complications. In otherwise healthy pediatric patients, even significant intra-operative blood loss can be safely managed solely with intravenous fluids and pRBC transfusion. What is Known: • Significant intra-operative blood loss and resultant transfusion may lead to postoperative coagulopathy. • There are potential deleterious effects from both coagulopathy and administration of blood products. What is New: • Open craniosynostosis corrective surgery is a useful model for studying coagulopathy after significant intra-operative blood loss and transfusion in otherwise healthy children. • Under certain conditions, in otherwise healthy pediatric patients, even significant intra-operative blood loss can be safely treated with intravenous fluids and pRBC transfusion alone, with no clinically significant postoperative coagulopathy or its complications.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Aneurysm IV: Nursing Management
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...

